Nalpha-fmoc-ndelta-trityl-l-ornithine is a doubly protected ornithine derivative used to install branching or reactive side-chain functionalities. The trityl group enables controlled deprotection for downstream modifications. Researchers use it in cyclic peptide synthesis and structure-guided design. Its versatility supports complex peptide assembly.
CAT No: R2132
CAS No:1998701-26-0
Synonyms/Alias:1998701-26-0;Fmoc-Orn(Trt)-OH;Nalpha-fmoc-ndelta-trityl-l-ornithine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-(tritylamino)pentanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tritylamino)pentanoic acid;DTXSID501153417;MFCD30478737;N-alpha-Fmoc-N-delta-trityl-L-Ornithine;AS-83863;E70922;N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N5-(triphenylmethyl)-L-ornithine;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5-[(triphenylmethyl)amino]pentanoic acid;(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-[(triphenylmethyl)amino]pentanoic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More